The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000097:blood; D000536:Aluminum Hydroxide / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000473:pathology; D002113:Calcification, Physiologic; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000008:administration & dosage / Q000627:therapeutic use*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000628:therapy; D010018:Osteomalacia / Q000473:pathology; D010758:Phosphorus / Q000097:blood; D011859:Radiography; D006435:Renal Dialysis
D010758:Phosphorus; D000536:Aluminum Hydroxide; D000469:Alkaline Phosphatase; D002119:Calcium Carbonate; D002118:Calcium